| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/16/2006 | US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | US7045520 Opioid receptor active compounds |
| 05/16/2006 | US7045152 Pulmonary disorders in which the S-nitrosoglutathione(GSNO) pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung an agent causing repletion of GSNO |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |
| 05/11/2006 | WO2006049286A1 Preventive/remedy for allergic diseases |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | WO2005044313A3 Conjugates of angiotensin ii and an imaging moiety |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060100276 Method of treating neutrophil-related diseases with topical anesthetics |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100233 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100202 Novel compounds |
| 05/11/2006 | US20060100159 Preventing desensitization of receptors |
| 05/11/2006 | US20060100141 Administering peptidic or peptidomimetic compound having segment competent for importation of molecule into mast cells, and asecond segment for having an anti-allergic effect within mast cells for reducing late phase inflammatory responses induced by mitogen activated protein kinase activation |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | US20060099257 Controlled drug delivery systems providing variable release rates |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2585535A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1655034A1 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | EP1379694B1 Methods and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1307189B1 Use of hydroxyethylrutosides for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1284738A4 (+) naloxone and epinephrine combination therapy |
| 05/10/2006 | EP1255764B1 Purine derivatives |
| 05/10/2006 | EP1194525B1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771239A Vitamin d3 lactone derivatives |
| 05/10/2006 | CN1769292A Barbat skullcap general flavone preparation method and quality control method |
| 05/10/2006 | CN1769286A Compound and pharmaceutical composition for treating nasal oversecreation and chronic obstructive pulmonary disease |
| 05/10/2006 | CN1768849A Cough treating Chinese medicinal formulation and its preparation process |
| 05/10/2006 | CN1768840A Method for preparing antiinflammation cough-stopping syrup |
| 05/10/2006 | CN1768828A Medicine for treating throat pain and hoarse voice |
| 05/10/2006 | CN1768826A Phlegm transforming Chinese medicinal formulation for children and its preparation method |
| 05/10/2006 | CN1768794A Chinese medicinal preparation for treating respiratory diseases and its preparing process |
| 05/10/2006 | CN1768793A Buccal tablet for mouth cavity and pharyngeal cavity inflammation based on mucus medicine |
| 05/10/2006 | CN1768787A Method for preparing cinobufotalin lyophilized powder |
| 05/10/2006 | CN1768785A Honey suckle and scutellaria root pill and preparation thereof |
| 05/10/2006 | CN1768752A Sustained release formulation with cetirizine and pseudoephedrine hydronate |
| 05/10/2006 | CN1768751A Method for preparing 'Fen Ma Mei Yu' dispersible tablet |
| 05/10/2006 | CN1768749A Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 05/10/2006 | CN1768738A Medical use of salvianolic acid B, its salt and other phenolic acid |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255522C Aqueous extract of irid and usage |
| 05/10/2006 | CN1255411C Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments |
| 05/10/2006 | CN1255406C Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods |
| 05/10/2006 | CN1255405C Substituted pyrazoles |
| 05/10/2006 | CN1255403C Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/10/2006 | CN1255170C Cough-relieving bagged tea |
| 05/10/2006 | CN1255168C External plaster for treating baby heat cough and preparing method |
| 05/10/2006 | CN1255161C Medication for relieving cough and asthma |
| 05/10/2006 | CN1255159C Chinese medicine for treating rhinitis |
| 05/10/2006 | CN1255158C Chinese medicine composition with action of nourishing lung, treating cough and relieving asthma and preparation process thereof |
| 05/10/2006 | CN1255146C Medicine composition for treating upper respiration channel infection and its preparing process |
| 05/10/2006 | CN1255132C Nasosinusitis treating medicine and its preparing process |
| 05/10/2006 | CN1255123C Lung-clearing asthma- stopping Chinese medicine and preparing process thereof |
| 05/10/2006 | CN1255118C Preparation process of coarse extrative of SARS virus resisting active matter from pore fungus |
| 05/10/2006 | CN1255049C Functional agent for decomposing nicotine and method of preparing the same |
| 05/09/2006 | US7041786 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II); |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | US7041638 Surfactant prevention of vaginitis and lung complications from cancer chemotherapy |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041288 Antiinflammatory agents; antiallergens |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | US7040311 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2395653C New inhalable powder containing tiotropium |
| 05/04/2006 | WO2006047427A1 M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders |
| 05/04/2006 | WO2006046910A1 Novel use |
| 05/04/2006 | WO2006046814A1 Sophorae subprostratae radix extract for prevention and treatment of respiratory diseases |
| 05/04/2006 | WO2006046739A1 Remedy for inflammatory diseases |
| 05/04/2006 | WO2006026998A8 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
| 05/04/2006 | WO2006009809A3 Vegf inhibitors for the treatment of malignant pleural effusion |
| 05/04/2006 | WO2005106492A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3) |
| 05/04/2006 | US20060094879 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 05/04/2006 | US20060094767 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 05/04/2006 | US20060094751 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094723 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094710 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 05/04/2006 | US20060094701 Respiratory system disorders; antiinflamamtory agents; side effect reduction; administering terbutaline |
| 05/04/2006 | US20060094688 Histamine release inhibitor |
| 05/04/2006 | US20060093690 Novel therapeutic use of polypodium extracts |
| 05/04/2006 | US20060093626 Lyophilization; conjugated Streptococcus pneumoniae capsular polysaccharide serotype is adjuvanted with 3-0 deacylated monophosphoryl lipid A (3D-MPL) and devoid of aluminium-based adjuvant |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |